BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18048844)

  • 1. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.
    Montaner J
    Stroke; 2008 Jan; 39(1):e6. PubMed ID: 18048844
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioembolic stroke in the THRombolysis and STatins (THRaST) study.
    Cappellari M; Bovi P; Toni D; Micheletti N; Tomelleri G; Carletti M; Moretto G
    Int J Stroke; 2015 Feb; 10(2):E22. PubMed ID: 25598034
    [No Abstract]   [Full Text] [Related]  

  • 3. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!
    Scheitz JF; Nolte CH; Endres M
    Stroke; 2013 May; 44(5):1472-6. PubMed ID: 23444304
    [No Abstract]   [Full Text] [Related]  

  • 4. Extending the time window for thrombolysis.
    Donnan GA; Davis SM
    Int J Stroke; 2019 Jul; 14(5):449. PubMed ID: 31436515
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis and hemorrhagic transformation.
    De Keyser J
    Stroke; 2002 Mar; 33(3):724. PubMed ID: 12532967
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis May Reduce the Incidence/Extent of Postprocedural Ischemic Strokes Associated With Carotid Artery Stenting: A Hypothesis.
    Paraskevas KI; Veith FJ
    Angiology; 2015 Aug; 66(7):604-6. PubMed ID: 25168957
    [No Abstract]   [Full Text] [Related]  

  • 8. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
    Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
    Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry.
    Libman R; Kwiatkowski T
    Stroke; 2007 Sep; 38(9):e88. PubMed ID: 17673802
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis in pediatric stroke study.
    Rivkin MJ; deVeber G; Ichord RN; Kirton A; Chan AK; Hovinga CA; Gill JC; Szabo A; Hill MD; Scholz K; Amlie-Lefond C
    Stroke; 2015 Mar; 46(3):880-5. PubMed ID: 25613306
    [No Abstract]   [Full Text] [Related]  

  • 12. First thrombolysis in acute stroke with tenecteplase in Congo.
    Ossou-Nguiet PM; Otiobanda GF; Ellenga-Mbolla BF; Ikama MS; Ondze Kafata LI; Bandzouzi-Ndamba B
    Int J Stroke; 2013 Oct; 8(7):E47. PubMed ID: 24024923
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers to delivery of thrombolysis for acute stroke.
    Barber M; Langhorne P; Stott DJ
    Age Ageing; 2004 Mar; 33(2):94-5. PubMed ID: 14960419
    [No Abstract]   [Full Text] [Related]  

  • 14. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established.
    Wechsler LR
    Stroke; 2014 Mar; 45(3):914-5. PubMed ID: 24526061
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis for intraventricular hemorrhage.
    Wong RH; Bailes JE
    Semin Thromb Hemost; 2013 Jun; 39(4):400-5. PubMed ID: 23446915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
    Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH
    Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 18. Wake-up to wake-up stroke!
    Chan RK
    Can J Neurol Sci; 2014 Mar; 41(2):137-8. PubMed ID: 24534019
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting rtPA associated ICH in acute stroke.
    Bruno A
    Stroke; 2004 Dec; 35(12):2762; author reply 2762-3. PubMed ID: 15514198
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.